Why, Why, Why…ELISA? A Look at the Benchmark HCP Assay
March 14, 2019 - Cytiva

Click here to read the article >>

Real-Time Characterization of Biotherapeutics and Comparability o


March 14, 2019 - BioPharm International

Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars

Bispecific Antibody Purification: Insights and Case Studies
February 28, 2019 - Cytiva

New modalities, like bispecific antibodies, present unique challenges compared to mAb production. For purification, there’s not just one right answer to which

Make the Switch from ELISA to Biacore™ SPR-Based Assays Today
February 28, 2019 - Cytiva direct binding assay

Protein Analysis with Size Exclusion Chromatography
February 28, 2019 - Cytiva

Size exclusion chromatography (SEC) is widely used in several different analytical applications from basic research to quality control of biotherapeutics. This

News: Cytiva Adds ELISA Kit to End-to-End HCP Monitoring Capabili


February 28, 2019 - Cytiva

Cytiva is pleased to announce the new Amers

Nurturing Knowledge from Disparate Data Streams
February 28, 2019 - BioPharm International

Leveraging vast quantities of analytical data requires digitaliz

Reduce Hands-On Time in Your Ion Exchange Chromatography Runs
February 14, 2019 - Cytiva IEX

Single-Step, Protein A Chromatography Process for Bispecific Anti


February 14, 2019 - Cytiva

A single-step downstream process using protein A chromatograp

Supply Chain Challenges for Single-Use Systems
February 14, 2019 - BioPharm International

Suppliers address the complexity of supplying disposable components to the global biopharmaceutical manufacturing industry.

Previous PageNext Page